Association between the (GT)n polymorphism of the HO-1 gene promoter region and cancer risk: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 11, 2014, Pages 4617-4622

  Zhang, Ling ^a   Song, Fang Fang ^a   Huang, Yu Bei ^a   Zheng, Hong ^a   Song, Feng Ju ^a   Chen, Ke Xin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Heme oxygenase 1; Meta analysis; Polymorphism

Indexed keywords

HEME OXYGENASE 1; HMOX1 PROTEIN, HUMAN; MICROSATELLITE DNA;

ALLELE; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; PROMOTER REGION; RISK; SQUAMOUS CELL CARCINOMA;

ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEME OXYGENASE-1; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK;

EID: 84903728271     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.11.4617     Document Type: Article

References (37)

1. Aruoma OI, Grootveld M, Bahorun T (2006). Free radicals in biology and medicine: from inflammation to biotechnology. Biofactors, 27, 1-3.
2. Berberat PO, Dambrauskas Z, Gulbinas A, et al (2005). Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res, 11, 3790-8.
3. Chang KW, Lee TC, Yeh WI, et al (2004). Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer, 91, 1551-5.
4. Chian S, Li YY, Wang XJ, et al (2014). Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the nrf2 pathway. Asian Pac J Cancer Prev, 15, 2911-6.
5. Datta D, Banerjee P, Gasser M, Waaga-Gasser AM, Pal S (2010). CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. J Biol Chem, 285, 36842-8.
6. Davies KJ (1995). Oxidative stress: the paradox of aerobic life. Biochem Soc Symp, 61, 1-31.
7. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
8. Deshane J, Wright M, Agarwal A (2005). Heme oxygenase-1 expression in disease states. Acta Biochim Pol, 52, 273-84.
9. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
10. Exner M, Minar E, Wagner O, Schillinger M (2004). The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med, 37, 1097-104.
11. Higgins JPT, Green S, eds (2009). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.2 [Updated September 2009]. The Cochrane Collaboration, Oxford.
12. Hirai H, Kubo H, Yamaya M, et al (2003). Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood, 102, 1619-24.
13. Hong CC, Ambrosone CB, Ahn J, et al (2007). Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, andHO-1), ironintake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 16, 1784-94.
14. Hu JL, Li ZY, Liu W, et al (2010). Polymorphism in heme oxygenase-1 (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males. Neoplasma, 57, 86-92.
15. Jiraskova A, Novotny J, Novotny L, et al (2012). Association of serum bilirubin and promoter variations in HMOX1and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer, 131, 1549-55.
16. Jozkowicz A, Was H, Dulak J (2007). Heme oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal, 9, 2099-117.
17. Kikuchi A, Yamaya M, Suzuki S, et al (2005). Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet, 116, 354-60.
18. Kimpara T, Takeda A, Watanabe K, et al (1997). Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet, 100, 145-7.
19. Li Q, Wang JM, Peng Y, et al (2013). Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Asian Pac J Cancer Prev, 14, 5145-51.
20. Li Y, Ambrosone CB, McCullough MJ, et al (2009). Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis, 30, 777-84.
21. Lin SC, Liu CJ, Yeh WI, et al (2006). Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett, 243, 47-54.
22. Lo SS, Lin SC, Wu CW, et al (2007). Heme Oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann Surg Oncol, 14, 2250-6.
23. Luo H, Li Z, Qing Y, et al (2014). Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population. Asian Pac J Cancer Prev, 15, 1133-40.
24. Maines MD (1997). The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol, 37, 517-54.
25. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
26. Marcos M, Gomez-Munuera M, Pastor I, Gonzalez-Sarmiento R, Laso FJ (2009). Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol, 170, 948-56.
27. Murakami A, Fujimori Y, Yoshikawa Y, et al (2012). Heme Oxygenase-1promoter polymorphism is associated with risk of malignant mesothelioma. Lung, 190, 333-7.
28. Nuhn P, Künzli BM, Hennig R, et al (2009). Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer, 8, 37
29. Okamoto I, Krögler J, Endler G, et al (2006). A microsatellite polymorphism in the heme oxygenase-1gene promoteris associated with risk for melanoma. Int J Cancer, 119, 1312-5.
30. Sacca P, Meiss R, Casas G, et al (2007). Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer, 97, 1683-9.
31. Sawa T, Mounawar M, Tatemichi M, et al (2008). Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-1 and the inducible nitric oxide synthase gene promoters. Cancer Lett, 269, 78-84.
32. Song F, Li X, Zhang M, et al (2009). Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Am J Epidemiol, 170, 747-56.
33. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12.
34. Vashist YK, Uzunoglu G, Cataldegirmen G, et al (2009). Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour. Histopathology, 54, 303-8.
35. Vashist YK, Uzungolu G, Kutup A, et al (2011). Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer. J Surg Oncol, 104, 305-11
36. Woolf B (1955). On estimating the relation between blood group and disease. Ann Hum Genet, 19, 251-3.
37. Yamada N, Yamaya M, Okinaga S, et al (2000). Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet, 66, 187-95.